Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06823089 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of Cartilage Defect Repair
A NA study of Osteoarthritis, Hip and Osteonecrosis, sponsored by Cytex Therapeutics.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06823089 is a NA study of Osteoarthritis, Hip and Osteonecrosis that is actively recruiting participants, run by Cytex Therapeutics. The registered enrollment target is 15 participants, below the 1,273-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06823089, a NA study of Osteoarthritis, Hip and Osteonecrosis, is actively recruiting participants, sponsored by Cytex Therapeutics.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Any patient aged 14 or older up to 64 years of age with hip disease, resulting in loss of articular cartilage integrity on the femoral head (e.g., femoroacetabular impingement or other structural deformity), has failed conservative care, and is a candidate for surgical intervention to treat.
Conditions Studied
Interventions
- DEVICE ReNew Hip Implant
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-11-06 |
| Est. Completion | 2031-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06823089
The ClinicalTrials.gov registry entry for NCT06823089 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,273-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (99% lower). The listed sponsor is Cytex Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 1 intervention - of which ReNew Hip Implant is the first listed.
NCT06823089 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06823089 about?
NCT06823089 is a clinical study titled "Early Feasibility Study of Cartilage Defect Repair". Any patient aged 14 or older up to 64 years of age with hip disease, resulting in loss of articular cartilage integrity on the femoral head (e.g., femoroacetabular impingement or other structural deformity), has failed conservative care, and is a candidate for surgical intervention to treat.
What is the current status of trial NCT06823089?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-11-06. Estimated completion is 2031-10.
What conditions does trial NCT06823089 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip, Osteonecrosis, Hip Dysplasia, Femoroacetabular Impingement, Legg-Calvé-Perthes Disease.
What interventions are being tested in trial NCT06823089?
The interventions under investigation include: ReNew Hip Implant (DEVICE).
Who is sponsoring clinical trial NCT06823089?
This trial is sponsored by Cytex Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06823089 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of the HIT Reverse HRS
RECRUITING · NA
-
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
RECRUITING · NA
-
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
RECRUITING · NA
-
Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain
RECRUITING · NA
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
RECRUITING · NA
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.